Research location
Flushing
New York, United States
Advertisement
Research activity in Flushing
New York, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 98 trials and 100 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Flushing
98 linked trials · page 2 of 2Study to Evaluate the Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Positive, Antiretroviral Treatment-Naive AdultsNCT01780506 · 2012-12-26 · 1 site observation
COMPLETED
Safety and Efficacy of E/C/F/TDF Versus RTV-Boosted ATV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment-Naive WomenNCT01705574 · 2012-10-24 · 1 site observation
COMPLETED
Comparison of Technosphere® Insulin Versus Technosphere Powder (Placebo) in Insulin-Naive Subjects With Type 2 Diabetes MellitusNCT01451398 · 2011-11-01 · 1 site observation
COMPLETED
Clinical Trial Evaluating Technosphere® Insulin Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus Over a 24-week Treatment PeriodNCT01445951 · 2011-09-01 · 1 site observation
COMPLETED
Efficacy and Safety of Empagliflozin (BI 10773) / Linagliptin (BI 1356) Fixed Dose Combination in Treatment naïve and Metformin Treated Type 2 Diabetes PatientsNCT01422876 · 2011-08-01 · 1 site observation
COMPLETED
A Prospective, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Atrasentan, Including Thoracic Bioimpedance, in Type 2 Diabetic Subjects With NephropathyNCT01399580 · 2011-08-01 · 1 site observation
COMPLETED
NBRST: Prospective Neo-adjuvant REGISTRY TrialNCT01479101 · 2011-07-01 · 1 site observation
COMPLETED
A Multicenter Study Comparing the Analgesic Effects and Safety of ABT-639 Compared to Placebo in Subjects With Diabetic Neuropathic PainNCT01345045 · 2011-04-01 · 1 site observation
COMPLETED
Study to Evaluate the Safety and Efficacy of a Single Tablet Regimen of Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Compared With a Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive AdultsNCT01309243 · 2011-02-01 · 1 site observation
COMPLETED
A Study of ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry StudyNCT01271959 · 2010-11-01 · 1 site observation
TERMINATED
JC Virus Antibody Study of Participants With Relapsing Forms of MS Receiving Treatment With NatalizumabNCT01070836 · 2010-03-01 · 1 site observation
COMPLETED
Study to Evaluate the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive AdultsNCT01095796 · 2010-03-01 · 1 site observation
COMPLETED
A Study in Participants With Type 2 Diabetes MellitusNCT01064687 · 2010-02-01 · 1 site observation
COMPLETED
CANVAS - CANagliflozin cardioVascular Assessment StudyNCT01032629 · 2009-12-09 · 1 site observation
COMPLETED
Comparison of NN1250 Plus Insulin Aspart With Insulin Glargine Plus Insulin Aspart in Type 1 DiabetesNCT00982228 · 2009-09-01 · 1 site observation
COMPLETED
Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney DiseaseNCT00811889 · 2009-04-30 · 1 site observation
COMPLETED
Study of FibroGen (FG)-3019 in Subjects With Type 2 Diabetes Mellitus and Kidney Disease on ACEi and/or ARB TherapyNCT00913393 · 2009-02-01 · 1 site observation
TERMINATED
A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea.NCT00755287 · 2008-11-01 · 1 site observation
COMPLETED
TMC278-TiDP6-C215: A Clinical Trial in Treatment Naive HIV-subjects Patients Comparing TMC278 to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase InhibitorsNCT00543725 · 2008-06-01 · 1 site observation
COMPLETED
Phase 1 Study of FG-3019 in Subjects With Type 1 or Type 2 Diabetes Mellitus and Diabetic NephropathyNCT00754143 · 2008-03-01 · 1 site observation
COMPLETED
A Study In Patients With Neuropathic Pain From Diabetic Peripheral Neuropathy (DPN)NCT00643760 · 2008-03-01 · 1 site observation
COMPLETED
Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung CancerNCT00499330 · 2007-10-12 · 1 site observation
ACTIVE_NOT_RECRUITING
GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung CancerNCT00480025 · 2007-10-04 · 1 site observation
TERMINATED
A 2-Month Safety Follow-Up TrialNCT00741429 · 2007-05-01 · 1 site observation
COMPLETED
A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 DiabetesNCT00474630 · 2007-05-01 · 1 site observation
COMPLETED
Screening for Early Evidence of DiabetesNCT00614783 · 2007-05-01 · 1 site observation
COMPLETED
Expanded Access Program for Maraviroc At Multiple CentersNCT00426660 · 2007-02-01 · 1 site observation
COMPLETED
Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung CancerNCT00367679 · 2006-11-01 · 1 site observation
COMPLETED
A Type 2 Diabetes Study of the Longer-Term Glycemic Effect of AVANDAMET vs. MetforminNCT00386100 · 2006-10-01 · 1 site observation
COMPLETED
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure TrialNCT00358215 · 2006-06-01 · 1 site observation
COMPLETED
Study Evaluating Desvenlafaxine Succinate Sustained-release (DVS SR) in Adult Outpatients With Pain Associated With Diabetic Peripheral NeuropathyNCT00283842 · 2006-03-01 · 1 site observation
TERMINATED
G-PLUS (GALLANT, GALLEX and ARMOR - Post Treatment Follow-up Study)NCT00255645 · 2005-09-01 · 1 site observation
TERMINATED
Study of Human Insulin Inhalation Powder in Patients With Type 1 DiabetesNCT00127634 · 2005-07-01 · 1 site observation
COMPLETED
Safety of Inhaled Insulin With Type 1 and Type 2 DiabetesNCT00308737 · 2005-06-01 · 1 site observation
COMPLETED
Trial of Maraviroc (UK-427,857) in Combination With Zidovudine/Lamivudine Versus Efavirenz in Combination With Zidovudine/LamivudineNCT00098293 · 2004-11-01 · 1 site observation
COMPLETED
ARMOR (Analyzing Renal Mechanisms of Creatinine Excretion in Patients On tesaglitazaR)NCT00229684 · 2004-09-01 · 1 site observation
TERMINATED
Irbesartan Versus Placebo in Combination With Ramipril for Treatment of AlbuminuriaNCT00095290 · 2004-09-01 · 1 site observation
COMPLETED
An Open-label, Multi-center, International, Three-year, Safety and Tolerability 'Follow on' TrialNCT00754624 · 2004-05-01 · 1 site observation
COMPLETED
A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study)NCT00168857 · 2003-07-09 · 1 site observation
COMPLETED
Safety and Efficacy of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus.NCT00063128 · 2003-04-01 · 1 site observation
COMPLETED
Demonstrate Exubera Works As Well As Avandia When Added To Sulfonylurea + Metformin In Controlling GlucoseNCT00150410 · 2003-01-01 · 1 site observation
COMPLETED
Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve)NCT00095238 · 2002-06-01 · 1 site observation
COMPLETED
Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And HypertensionNCT00060931 · 2001-06-01 · 1 site observation
COMPLETED
Iressa Expanded Access Program (EAP)NCT00034879 · 2000-08-01 · 1 site observation
COMPLETED
Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/GlibenclamideNCT00279045 · 2000-01-03 · 1 site observation
COMPLETED
Warfarin and Antiplatelet Therapy in Chronic Heart FailureNCT00007683 · 1998-10-01 · 1 site observation
COMPLETED
TMC114-C226: An Early Access Program to Evaluate the Long-term Safety and Tolerability of TMC114 Combined With a Low Dose of Ritonavir (TMC114/r) With Other Antiretrovirals, for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens.NCT00245739 · 1 site observation
APPROVED_FOR_MARKETING
A Comparison of Two Dose Levels of Indinavir Combined With Two Nucleoside Analogue Reverse Transcriptase Inhibitors (NRTIs) in HIV-Infected PatientsNCT00002406 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.